Literature DB >> 32950933

Dengue mouse models for evaluating pathogenesis and countermeasures.

Rita E Chen1, Michael S Diamond2.   

Abstract

Dengue virus (DENV) causes the most prevalent arbovirus illness worldwide and is responsible for many debilitating epidemics. The four circulating DENV serotypes infect humans and can cause asymptomatic, mild, moderate, or severe Dengue. Because of the global morbidity and mortality due to Dengue, deployment of a safe and effective tetravalent vaccine has been a high priority, and to date, a partially realized goal. The study of pathogenesis and development of DENV therapeutics and vaccines has been limited by few animal models that recapitulate key features of human disease. Over the past two decades, mouse models of DENV infection have evolved with increasing success. Here, we review the utilization and limitations of mice for studying DENV pathogenesis and evaluating countermeasures.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32950933      PMCID: PMC7774505          DOI: 10.1016/j.coviro.2020.09.001

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.121


  107 in total

1.  Construction of a novel tetravalent dengue vaccine with a Salmonella Typhimurium bacterial ghost and evaluation of its immunogenicity and protective efficacy using a murine model.

Authors:  Eunha Kim; Gayeon Won; John Hwa Lee
Journal:  Vaccine       Date:  2019-11-06       Impact factor: 3.641

2.  Using a Virion Assembly-Defective Dengue Virus as a Vaccine Approach.

Authors:  Chao Shan; Xuping Xie; Jing Zou; Roland Züst; Bo Zhang; Rebecca Ambrose; Jason Mackenzie; Katja Fink; Pei-Yong Shi
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

3.  Risk factors in dengue shock syndrome.

Authors:  S Thein; M M Aung; T N Shwe; M Aye; A Zaw; K Aye; K M Aye; J Aaskov
Journal:  Am J Trop Med Hyg       Date:  1997-05       Impact factor: 2.345

4.  Development of a novel mouse model for dengue virus infection.

Authors:  J An; J Kimura-Kuroda; Y Hirabayashi; K Yasui
Journal:  Virology       Date:  1999-10-10       Impact factor: 3.616

5.  Dengue Virus M Protein Promotes NLRP3 Inflammasome Activation To Induce Vascular Leakage in Mice.

Authors:  Pan Pan; Qi Zhang; Weiyong Liu; Yingle Liu; Geng Li; Jianguo Wu; Wenbiao Wang; Zizhao Lao; Wei Zhang; Miaomiao Shen; Pin Wan; Feng Xiao; Fang Liu; Wen Zhang; Quiping Tan; Xiaohong Liu; Kailang Wu
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

6.  A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice.

Authors:  Claude Roth; Tineke Cantaert; Chloé Colas; Matthieu Prot; Isabelle Casadémont; Laurine Levillayer; Jessie Thalmensi; Pierre Langlade-Demoyen; Christiane Gerke; Kapil Bahl; Giuseppe Ciaramella; Etienne Simon-Loriere; Anavaj Sakuntabhai
Journal:  Front Immunol       Date:  2019-06-21       Impact factor: 7.561

7.  Cross-Protection Against Four Serotypes of Dengue Virus in Mice Conferred by a Zika DNA Vaccine.

Authors:  Ran Wang; Na Gao; Yun Li; Dongying Fan; Zida Zhen; Kaihao Feng; Hui Chen; Jing An
Journal:  Front Cell Infect Microbiol       Date:  2019-05-08       Impact factor: 5.293

8.  Zika virus envelope nanoparticle antibodies protect mice without risk of disease enhancement.

Authors:  Rahul Shukla; Rajgokul K Shanmugam; Viswanathan Ramasamy; Upasana Arora; Gaurav Batra; Joshua A Acklin; Florian Krammer; Jean K Lim; Sathyamangalam Swaminathan; Navin Khanna
Journal:  EBioMedicine       Date:  2020-04       Impact factor: 8.143

9.  Characterization of a murine model of non-lethal, symptomatic dengue virus infection.

Authors:  Vanessa V Sarathy; Mellodee White; Li Li; Jaclyn A Kaiser; Gerald A Campbell; Gregg N Milligan; Nigel Bourne; Alan D T Barrett
Journal:  Sci Rep       Date:  2018-03-20       Impact factor: 4.379

Review 10.  Fc receptors in antibody-dependent enhancement of viral infections.

Authors:  Adam Taylor; Suan-Sin Foo; Roberto Bruzzone; Luan Vu Dinh; Nicholas J C King; Suresh Mahalingam
Journal:  Immunol Rev       Date:  2015-11       Impact factor: 12.988

View more
  11 in total

1.  Zika Virus Replicates in the Vagina of Mice with Intact Interferon Signaling.

Authors:  Cesar A Lopez; Sarah J Dulson; Helen M Lazear
Journal:  J Virol       Date:  2022-08-30       Impact factor: 6.549

Review 2.  Innate Immune Response to Dengue Virus: Toll-like Receptors and Antiviral Response.

Authors:  Caroline Fernandes-Santos; Elzinandes Leal de Azeredo
Journal:  Viruses       Date:  2022-05-07       Impact factor: 5.818

3.  Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity.

Authors:  Rita E Chen; Brittany K Smith; John M Errico; David N Gordon; Emma S Winkler; Laura A VanBlargan; Chandni Desai; Scott A Handley; Kimberly A Dowd; Emerito Amaro-Carambot; M Jane Cardosa; Carlos A Sariol; Esper G Kallas; Rafick-Pierre Sékaly; Nikos Vasilakis; Daved H Fremont; Stephen S Whitehead; Theodore C Pierson; Michael S Diamond
Journal:  Cell Host Microbe       Date:  2021-10-04       Impact factor: 31.316

4.  Evaluation of Aedes aegypti, Aedes albopictus, and Culex quinquefasciatus Mosquitoes Competence to Oropouche virus Infection.

Authors:  Silvana F de Mendonça; Marcele N Rocha; Flávia V Ferreira; Thiago H J F Leite; Siad C G Amadou; Pedro H F Sucupira; João T Marques; Alvaro G A Ferreira; Luciano A Moreira
Journal:  Viruses       Date:  2021-04-25       Impact factor: 5.048

5.  Generation and Characterization of Human-Mouse STING Chimeras That Allow DENV Replication in Mouse Cells.

Authors:  Tongtong Zhu; Laurence G Webb; Jeury Veloz; Maris Wilkins; Sebastian Aguirre; Ana Fernandez-Sesma
Journal:  mSphere       Date:  2022-04-28       Impact factor: 5.029

6.  A single-dose live attenuated chimeric vaccine candidate against Zika virus.

Authors:  Wei-Xin Chin; Regina Ching Hua Lee; Parveen Kaur; Tian Sheng Lew; Thinesshwary Yogarajah; Hao Yuin Kong; Zi-Yun Teo; Cyrill Kafi Salim; Rong-Rong Zhang; Xiao-Feng Li; Sylvie Alonso; Cheng-Feng Qin; Justin Jang Hann Chu
Journal:  NPJ Vaccines       Date:  2021-01-29       Impact factor: 7.344

7.  Contact System Activation in Plasma from Dengue Patients Might Harness Endothelial Virus Replication through the Signaling of Bradykinin Receptors.

Authors:  Sharton V A Coelho; Naiara M Rust; Lucas Vellasco; Michelle P Papa; Aline S G Pereira; Matheus Ferreira da Silva Palazzo; Maria Aparecida Juliano; Simone M Costa; Ada M B Alves; Marli T Cordeiro; Ernesto T A Marques; Júlio Scharfstein; Luciana B de Arruda
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-12

8.  Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice.

Authors:  Ji Ma; Robbert Boudewijns; Lorena Sanchez-Felipe; Niraj Mishra; Thomas Vercruysse; Dieudonné Buh Kum; Hendrik Jan Thibaut; Johan Neyts; Kai Dallmeier
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

9.  Editorial: Balanced and Unbalanced Immune Response to Dengue Virus in Disease Protection and Pathogenesis.

Authors:  Tineke Cantaert; Nolwenn Jouvenet; Sean A Diehl
Journal:  Front Immunol       Date:  2022-02-11       Impact factor: 7.561

Review 10.  Pathogen Dose in Animal Models of Hemorrhagic Fever Virus Infections and the Potential Impact on Studies of the Immune Response.

Authors:  Bryce M Warner
Journal:  Pathogens       Date:  2021-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.